|
21-May-2012
Elsevier Global Medical News
SAN FRANCISCO (EGMN) – Patients aged 55-74 years who have at least a 30 pack-year smoking history...
|
17-May-2012
Elsevier Global Medical News
The recently approved cancer drug crizotinib draws strong responses in children whose cancers have...
|
16-May-2012
Elsevier Global Medical News
GLASGOW, SCOTLAND (EGMN) – The presence of specific autoantibodies may help to predict which...
|
15-May-2012
Elsevier Global Medical News
GLASGOW, SCOTLAND (EGMN) – Patients who smoke are substantially less likely to respond to biologic...
|
10-May-2012
Elsevier Global Medical News
GLASGOW (EGMN) – Biologic treatment for rheumatoid arthritis does not increase the overall risk of...
|
07-May-2012
Elsevier Global Medical News
ORLANDO (EGMN) – Intensive follow-up of patients who have undergone surgery for hepatocellular...
|
23-Apr-2012
Elsevier Global Medical News
CHICAGO (EGMN) – Maintenance immunotherapy with low-dose interleukin-2 and 13-cis-retinoic acid...
|
16-Apr-2012
Elsevier Global Medical News
Adding bevacizumab to standard first-line carboplatin and paclitaxel chemotherapy didn’t improve...
|
09-Apr-2012
Elsevier Global Medical News
CHICAGO (EGMN) – Combination therapy with nanoparticle albumin bound–paclitaxel and carboplatin may...
|
06-Apr-2012
Elsevier Global Medical News
DENVER (EGMN)–The routine administration of oxygen to terminally ill patients who are near death is...
|
|
